Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Brach

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|February 1, 1995
Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblastsM Kiehntopf, F Herrmann, M A Brach
Cancer Investigation|January 1, 1993
Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokinesM A Brach, R H Mertelsmann, F Herrmann
Blood|February 1, 1992
Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cellsM A Brach, F Herrmann, D W Kufe
Seminars in Oncology|April 1, 1992
Hematopoietins in combination with 1-beta-D-arabinofuranosylcytosine: a possible strategy for improved treatment of myeloid disordersM A Brach, R H Mertelsmann, F Herrmann
Blood|November 15, 1992
Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factorH J Gruss, M A Brach, F Herrmann
Seminars in Hematology|July 1, 1991
To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?M A Brach, R Henschler, R Mertelsmann, et al.
European Journal of Immunology|March 1, 1994
Expression of the transforming growth factor-alpha gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factorM A Brach, C Sott, M Kiehntopf, et al.
Deutsche Medizinische Wochenschrift (1946)|January 20, 1995
[Molecular basis of tumor formation. Significance for the diagnosis of malignant diseases]M A Brach, C Sott, C Belka, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1991
Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa BM A Brach, R Henschler, R H Mertelsmann, et al.
Leukemia|September 1, 1990
Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cellsM A Brach, D Riedel, R H Mertelsmann, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|February 1, 1995
Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblastsM Kiehntopf, F Herrmann, M A Brach
Cancer Investigation|January 1, 1993
Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokinesM A Brach, R H Mertelsmann, F Herrmann
Blood|February 1, 1992
Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cellsM A Brach, F Herrmann, D W Kufe
Seminars in Oncology|April 1, 1992
Hematopoietins in combination with 1-beta-D-arabinofuranosylcytosine: a possible strategy for improved treatment of myeloid disordersM A Brach, R H Mertelsmann, F Herrmann
Blood|November 15, 1992
Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factorH J Gruss, M A Brach, F Herrmann
Seminars in Hematology|July 1, 1991
To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?M A Brach, R Henschler, R Mertelsmann, et al.
European Journal of Immunology|March 1, 1994
Expression of the transforming growth factor-alpha gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factorM A Brach, C Sott, M Kiehntopf, et al.
Deutsche Medizinische Wochenschrift (1946)|January 20, 1995
[Molecular basis of tumor formation. Significance for the diagnosis of malignant diseases]M A Brach, C Sott, C Belka, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1991
Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa BM A Brach, R Henschler, R H Mertelsmann, et al.
Leukemia|September 1, 1990
Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cellsM A Brach, D Riedel, R H Mertelsmann, et al.
Pageof 7